August 11, 2026
UHCOP researchers have secured more than $1 million in new funding for three projects targeting major health challenges. The studies explore a novel nanomedicine for sepsis, artificial intelligence-assisted drug repurposing for Alzheimer’s disease and related dementias, and a new depression screening tool designed for people living with sickle cell disease.